These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17004186)

  • 1. [Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication].
    Junginger T; Hermanek P; Oberholzer K; Schmidberger H
    Zentralbl Chir; 2006 Aug; 131(4):275-84. PubMed ID: 17004186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
    Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
    Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rectal carcinoma--oncologically adequate resection].
    Simon D
    Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality indicators for diagnostic and therapy of rectal carcinoma].
    Bittner R; Burghardt J; Gross E; Grundmann RT; Hermanek P; Isbert C; Junginger T; Köckerling F; Merkel S; Möslein G; Raab HR; Roder J; Ruf G; Schwenk W; Strassburg J; Tannapfel A; de Vries A; Zühlke H
    Zentralbl Chir; 2007 Apr; 132(2):85-94. PubMed ID: 17516312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study.
    Strassburg J; Ruppert R; Ptok H; Maurer C; Junginger T; Merkel S; Hermanek P
    Ann Surg Oncol; 2011 Oct; 18(10):2790-9. PubMed ID: 21509631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
    Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and imaging of low rectal carcinoma.
    Salerno G; Daniels I; Heald RJ; Brown G; Moran BJ
    Surg Oncol; 2004; 13(2-3):55-61. PubMed ID: 15572087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal cancer: review with emphasis on MR imaging.
    Beets-Tan RG; Beets GL
    Radiology; 2004 Aug; 232(2):335-46. PubMed ID: 15286305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications.
    Ratto C; Ricci R; Valentini V; Castri F; Parello A; Gambacorta MA; Cellini N; Vecchio FM; Doglietto GB
    Ann Surg Oncol; 2006 Nov; 13(11):1393-402. PubMed ID: 17013687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of rectal cancer within the circumference of the rectum does not influence lymph node status.
    Ulrich A; Himmer K; Koch M; Kienle P; Büchler MW; Weitz J
    Ann Surg Oncol; 2007 Aug; 14(8):2257-62. PubMed ID: 17520316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant radiochemotherapy for rectal cancer.
    Vini L
    Dig Dis; 2007; 25(1):56-66. PubMed ID: 17384509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of pelvic recurrence by preoperative radiochemotherapy and total mesorectal excision of rectal carcinoma?].
    Bosset JF; Horiot JC
    Praxis (Bern 1994); 2001 Apr; 90(14):581-6. PubMed ID: 11320885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision.
    Colquhoun P; Wexner SD; Cohen A
    J Surg Oncol; 2003 Jul; 83(3):133-9. PubMed ID: 12827680
    [No Abstract]   [Full Text] [Related]  

  • 15. The circumferential resection margin in rectal carcinoma surgery.
    Hermanek P; Junginger T
    Tech Coloproctol; 2005 Dec; 9(3):193-9; discussion 199-200. PubMed ID: 16328130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer].
    Rödel C; Sauer R; Fietkau R
    Strahlenther Onkol; 2009 Aug; 185(8):488-92. PubMed ID: 19652930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy of rectal cancer].
    Balteskard L; Vonen B; Frykholm G; Dahl O; Tveit KM
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3090-3. PubMed ID: 18049501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.
    Daniels IR; Fisher SE; Heald RJ; Moran BJ
    Colorectal Dis; 2007 May; 9(4):290-301. PubMed ID: 17432979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.